Successful treatment of clozapine-nonresponsive refractory hallucinations and delusions with pimavanserin, a serotonin 5HT-2A receptor inverse agonist.
第一作者:
Henry A,Nasrallah
第一单位:
Saint Louis University, Department of Psychiatry and Behavioral Neuroscience, St. Louis, MO, United States of America. Electronic address: henry.nasrallah@health.slu.edu.
作者:
医学主题词
成年人(Adult);老年人(Aged);抗精神病药(Antipsychotic Agents);氯氮平(Clozapine);妄想(Delusions);抗药性(Drug Resistance);女(雌)性(Female);幻觉(Hallucinations);人类(Humans);男(雄)性(Male);中年人(Middle Aged);哌啶类(Piperidines);精神病(Psychotic Disorders);回顾性研究(Retrospective Studies);精神分裂症(Schizophrenia);血清素5-HT2受体拮抗剂(Serotonin 5-HT2 Receptor Antagonists);尿素(Urea);青年人(Young Adult)
DOI
10.1016/j.schres.2019.02.018
PMID
30837203
发布时间
2020-07-02
- 浏览4
Schizophrenia research
217-220页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



